NOUV.US Nouveau Life Pharmaceuticals Inc

Healthcare Health Care Technology USA Stocks
0.0001 USD
Close of Feb 25, 2026
Market cap
USD 666K
P/E
-
P/B
22.72x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2025.

Is NOUV.US undervalued?

Graham number

The Graham number of Nouveau Life Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nouveau Life Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Nouveau Life Pharmaceuticals Inc yet.

Nouveau Life Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nouveau Life Pharmaceuticals Inc

Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and artificial intelligence (AI)-based healthcare devices and wearables. The company w…

Full company profile